Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News New non-invasive glaucoma therapy makes U.S. debut at Glaucoma Center of San Francisco First U.S. patient receives Eyetronic nerve stimulation for glaucoma; early data expected 2026 as non-invasive therapy shows promise. bySoujanya RaviJuly 21, 2025